Oxidative mechanisms in the pathogenesis of alcoholic liver disease

Molecular Aspects of Medicine

Volumn 29, Issue 1-2, 2008, Pages 9-16

  Albano, Emanuele ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Ethanol; Free radicals; Inflammation; Lipid peroxidation; Liver fibrosis; Steatosis

Indexed keywords

ANTIOXIDANT; COLLAGEN; CYTOKINE; FREE RADICAL; LIVER PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ALCOHOL LIVER DISEASE; APOPTOSIS; CELL DEATH; CYTOKINE RELEASE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FATTY LIVER; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; LIPID METABOLISM; LIPID PEROXIDATION; LIVER CELL; LIVER FIBROSIS; MALLORY BODY; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN METABOLISM; REVIEW; STELLATE CELL;

ANIMALS; HUMANS; LIPID METABOLISM; LIPID PEROXIDATION; LIVER CIRRHOSIS, ALCOHOLIC; LIVER DISEASES, ALCOHOLIC; OXIDATIVE STRESS;

EID: 39749090649     PISSN: 00982997     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mam.2007.09.004     Document Type: Review

References (64)

1. Adachi M., and Ishii H. Role of mitochondria in alcoholic liver injury. Free Rad. Biol. Med. 32 (2002) 487-491
2. Adachi M., Higuchi H., Miura S., Azuma T., Inokuchi S., Saito H., Kato S., and Ishii H. Bax interacts with voltage-dependent anion channel and mediates ethanol-induced apoptosis in rat hepatocytes. Am. J. Physiol. 287 (2004) G695-G705
3. Albano E. Alcohol, oxidative stress and free radical damage. Proc. Nutr. Soc. 65 (2006) 278-290
4. Albano E., Mottaran E., Vidali M., Vidali M., Reale E., Saksena S., Occhino D., Burt A.D., and Day C.P. Immune response toward lipid peroxidation products as a predictor of the progression of non-alcoholic fatty liver disease (NAFLD) to advanced fibrosis. Gut 54 (2005) 987-993
5. Arteel G.E. Oxidant and antioxidant in alcohol-induced liver disease. Gastroenterologia 124 (2003) 778-790
6. Bailey S.M., and Cunningham C.C. Contribution of mitochondria to oxidative stress associated with alcohol liver disease. Free Rad. Biol. Med. 32 (2002) 11-16
7. Bailey S.M., Robinson G., Pinner A., Chamlee L., Ulasova E., Pompilius M., Page Gp., Chhieng D., Jhala N., Landar A., Kharbanda K.K., Ballinger S., and Darley-Usmar V. S-Adenosylmethionine prevents chronic alcohol-induced mitochondrial dysfunction in the rat liver. Am. J. Physiol. 291 (2006) G857-G867
8. Bardag-Gorce F., French B.A., Nan L., Song H., Nguyen S.K., Yong H., Dede J., and French S.W. CYP2E1 induced by ethanol causes oxidative stress, proteasome inhibition and cytokeratin aggresome (Mallory body-like) formation. Exp. Mol. Pathol. 81 (2006) 191-201
9. Batey R.G., Cao Q., and Gould B. Lymphocyte-mediated liver injury in alcohol-related hepatitis. Alcohol 27 (2002) 37-41
10. Bloch-Damti A., and Bashan N. Proposed mechanisms for the induction of insulin resistance by oxidative stress. Antioxid. Redox. Signal. 7 (2005) 1553-1567
11. Bugianesi E., McCullough A.J., and Marchesini G. Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology 42 (2005) 978-1000
12. Cao Q., Mak K.M., and Lieber C.S. Cytochrome P4502E1 primes macrophages to increase TNF-alpha production in response to liposaccaride. Am. J. Physiol. 289 (2005) G95-G107
13. Caro A.A., and Cederbaum A.I. Oxidative stress, toxicology and pharmacology of CYP2E1. Ann. Rev. Pharmacol. Toxicol. 44 (2004) 27-42
14. Chedid A., Mendenhall C.L., Moritz T.E., French S.A., Chen T.S., Morgan T.R., Rosselle G.A., Nemchausky B.A., Taburro C.H., Schiff E.R., McClain G.J., Marsano L.S., Allen J.I., Samanta A., Weesner R.E., Henderson W.G., and Veteran Affairs Cooperative Group 275. Cell-mediated hepatic injury in alcoholic liver disease. Veterans Affairs Cooperative Study Group 275. Gastroenterologia 105 (1993) 254-266
15. Colombat M., Charlotte F., Ratziu V., and Poyard T. Portal lymphocytic infiltrate in alcoholic liver disease. Hum. Pathol. 33 (2002) 1170-1174
16. Crabb D.W., and Liangpunsakul S. Alcohol and lipid metabolism. J. Gastroenterol. Hepatol. 21 (2006) S56-S60
17. Day C.P. Genes or environment to determine alcoholic liver disease and non-alcoholic fatty liver disease. Liver Int. 26 (2006) 1021-1028
18. Dey A., and Cederbaum A.I. Alcohol and oxidative liver injury. Hepatology 43 (2006) S63-S74
19. Donohue Jr. T.M. The ubiquitin-proteasome system and its role in ethanol-induced disorders. Addict. Biol. 7 (2002) 15-28
20. Fang C., Lindros K.O., Badger T.M., Ronis J.J., and Ingelman-Sundberg M. Zonated expression of cytokines in rat liver: effect of chronic ethanol and cytochrome P4502E1 inhibitor, chlormethiazole. Hepatology 27 (1998) 1304-1310
21. Fernandez-Checa J.C., and Kaplowitz N. Hepatic mitochondrial glutathione: transport and role in disease and toxicity. Toxicol. Appl. Pharmacol. 204 (2005) 263-273
22. Fromenty B., Grimbert S., Mansouri A., Beaugrand M., Erlinger S., Röting A., and Pessayre D. Hepatic mitochondrial DNA deletion in alcoholics: association with microvesicular steatosis. Gastroenterologia 108 (1995) 193-200
23. Ganz T., and Nemeth E. Iron Imports. IV. Hepcidin and the regulation of body iron metabolism. Am. J. Physiol. 290 (2006) G199-G203
24. Greemberg M.E., Sun M., Zhang R., Febbraio M., Silverstein R., and Hazen S.L. Oxidized phosphatidylserine-CD36 interactions play an essential role in macrophage-dependent phagocytosis of apoptotic cells. J. Exp. Med. 203 (2006) 2613-2625
25. Green D.R., and Kroemer G. The pathophysiology of mitochondrial cell death. Sciences 305 (2004) 626-629
26. Gregory C.D., and Devitt A. The macrophage and the apoptotic cell: an innate immune interaction viewed simplistically?. Immunologist 113 (2004) 1-14
27. Harrison-Findik D.D., Shafer D., Klein E., Timchenko N., Kulaksiz H., Clemens D., Fein E., Adrianopulos B., Pantopoulos K., and Gollan J. Alcohol metabolism-mediated oxidative stress down-regulates hepcidin transcription and leads to increased duodenal iron transporter expression. J. Biol. Chem. 281 (2006) 22974-22992
28. Hines I.N., and Wheeler M.D. Recent advances in alcoholic liver disease III. Role of the innate immune response in alcoholic hepatitis. Am. J. Physiol. 287 (2004) G310-G314
29. Hoek J.B., Cahill A., and Pastorino J.G. Alcohol and mitochondria: a dysfunctional relationship. Gastroenterologia 122 (2002) 2049-2063
30. Hoek J.B., and Pastorino J.G. Cellular signalling mechanisms in alcoholic liver damage. Semin. Liver Dis. 24 (2004) 257-272
31. Houstis N., Rosen E.D., and Lander E.S. Reactive oxygen species have a casual role in multiple forms of insulin resistance. Nature 440 (2006) 944-948
32. Jaeschke H. Neutrophil-mediated tissue injury in alcoholic hepatitis. Alcohol 27 (2002) 23-27
33. Jarvelainen H.A., Fang C., Ingelman-Sundberg M., and Lindros K.O. Effect of chronic coadministration of endotoxin and ethanol on rat liver pathology and proinflammatory and anti-inflammatory cytokines. Hepatology 29 (1999) 1503-1510
34. Kagan V.E., Borisenko G.G., Serinkan B.F., Tyurina Y.Y., Tyurin V.A., Jiang J., Liu S.X., Shvedova A.A., Fabisial J.P., Uthsaisang W., and Fadeel B. Appetizing rancidity of apoptotic cells for macrophages: oxidation, externalization and recognition of phosphatidylserine. Am. J. Physiol. 285 (2003) L1-L17
35. Kita H., Mackay I.R., Van de Water J., and Gershwin E.M. The lymphoid liver: considerations on pathways to autoimmune injury. Gastroenterologia 120 (2001) 1485-1501
36. Mansouri A., Fromenty B., Berson A., Robin M.A., Grimbert S., Beaugrand M., Erlinger S., and Pessayre D. Multiple hepatic mitochondrial DNA deletions suggest premature oxidative aging in alcoholics. J. Hepatol. 27 (1997) 96-102
37. McFarlane I.G. Autoantibodies in alcoholic liver disease. Addict. Res. 5 (2000) 141-151
38. Mottaran E., Stewart S.F., Rolla R., Vay D., Cipriani V., Moretti M.G., Vidali M., Sartori M., Rigamonti C., Day C.P., and Albano E. Lipid peroxidation contributes to immune reactions associated with alcoholic liver disease. Free Rad. Biol. Med. 32 (2002) 38-48
39. Nagy L.E. Recent insights into the role of the innate immune system in the development of alcoholic liver disease. Exp. Biol. Med. 228 (2003) 882-890
40. Nanji A.A. Role of different dietary fatty acids in the pathogenesis of experimental alcoholic liver disease. Alcohol 34 (2004) 21-25
41. Nanji A.A., Jokelainen K., Tipoe G.L., Rahemtulla A., Thomas P., and Dannenberg A.J. Curcumin prevents alcohol-induced liver disease in rats by inhibiting the expression of NF-kB-dependent genes. Am. J. Physiol. 284 (2003) G321-G327
42. Natori S., Rust C., Stadheim L.M., Srinivasan A., Burgart L.J., and Gores G.J. Hepatocyte apoptosis is a pathological feature of human alcoholic hepatitis. J. Hepatol. 34 (2001) 248-253
43. Nieto N. Ethanol and fish oil induce NFkB transactivation of the collagen α2(1) promoter through lipid peroxidation-driven activation of PKC-PI3K-Akt pathway. Hepatology 45 (2007) 1433-1445
44. Pan M., Cederbaum A.I., Zhang Y.L., Ginsberg H.N., Williams K.J., and Fisher E.A. Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production. J. Clin. Invest. 113 (2004) 1277-1287
45. Parola M., and Robino G. Oxidative stress-related molecules and liver fibrosis. J. Hepatol. 35 (2001) 297-306
46. Pessayre D., and Fromenty B. NASH a mitochondrial disease. J. Hepatol. 42 (2005) 928-940
47. Powel E.E., Jonsson J.R., and Clouston A.D. Steatosis: co-factor in other liver diseases. Hepatology 42 (2005) 5-13
48. Rao R.K., Seth A., and Sheth P. Recent advances in alcoholic liver disease. I. Role of intestinal permeability and endotoxemia in alcoholic liver disease. Am. J. Physiol. 286 (2004) G881-G884
49. Rolla R., Vay D., Mottaran E., Parodi M., Vidali M., Sartoris M., Rigamonti C., Bellomo G., and Albano E. Antiphospholipid antibodies associated with alcoholic liver disease specifically recognise oxidised phospholipids. Gut 49 (2001) 852-859
50. Rolla R., Vay D., Mottaran E., Parodi M., Traverso N., Arico S., Sartori M., Bellomo G., Klassen L.W., Thiele G.M., Tuma D.J., and Albano E. Detection of circulating antibodies against malondialdehyde-acetaldehyde adducts in patients with alcohol-induced liver disease. Hepatology 31 (2002) 878-884
51. Ronis M.J.J., Hakkak R., Korourian S., Albano E., Yoon S., Ingelman-Sundberg M., Lindros K.O., and Badger T.M. Alcoholic liver disease in rats fed ethanol as part of oral or intragastric low-carbohydrate diets. Exp. Biol. Med. 229 (2004) 351-360
52. Ronis M.J.J., Butura A., Sampey B.P., Prior R.L., Korourian S., Albano E., Ingelman-Sundberg M., Petersen D.R., and Badger T.M. Effects of N-acetyl cysteine on ethanol-induced hepatotoxicity in rats fed via total enteral nutrition. Free Rad. Biol. Med. 39 (2005) 619-630
53. Safadi R., Ohta M., Alvarez C.E., Fiel M.I., Bansal M., Mehal W.Z., and Friedman S.L. Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes. Gastroenterologia 127 (2004) 870-882
54. Sampey B.P., Stewart B.J., and Petersen D.R. Ethanol-induced modulation of hepatocellular extracellular signal-regulated kinase 1/2 activity via 4-hydroxynonenal. J. Biol. Chem. 282 (2007) 1925-1937
55. Schwabe R.F., and Brenner D.A. Mechanisms of liver injury. I. TNF-α-induced liver injury: role of IKK, JNK and ROS pathways. Am. J. Physiol. 290 (2006) G583-G589
56. Shattemberg J.M., Wang Y., Singh R., Rigoli R.M., and Czaja M.J. Hepatocyte CYP2E1 overexpression and steatohepatits lead to impaired hepatic insulin signalling. J. Biol. Chem. 280 (2005) 9887-9894
57. Shulga N., Hoek J.B., and Pastorino J.G. Elevated PTEN levels account for the increased sensitivity of ethanol-exposed cells to tumor necrosis factor-induced cytotoxicity. J. Biol. Chem. 280 (2005) 9416-9424
58. Stewart S.F., Vidali M., Day C.P., Albano E., and Jones D.E.J. Oxidative stress as a trigger for cellular immune response in patients with alcoholic liver disease. Hepatology 39 (2004) 197-203
59. Thakur V., Pritchard M.T., McMullen M.R., Wang Q., and Nagy L.E. Chronic ethanol feeding increases activation of NADPH oxidase by liposaccaride in rat Kupffer cells: role of increased reactive oxygen in LPS-stimulated ERK1/2 activation and TNF-alpha production. J. Leukocyte Biol. 79 (2006) 1348-1356
60. Thiele G.M., Freeman T.K., and Klassen L.W. Immunological mechanisms of alcoholic liver disease. Semin. Liver Dis. 24 (2004) 273-287
61. Tsukamoto H., and Lu S.C. Current concepts in the pathogenesis of alcoholic liver injury. FASEB J. 15 (2001) 1335-1349
62. Vay D., Rigamonti C., Vidali M., Mottaran E., Alchera E., Occhino G., Sartori M., and Albano E. Anti-phospholipid antibodies associated with alcoholic liver disease target oxidized phosphatidylserine on apoptotic cell plasma membranes. J. Hepatol. 44 (2006) 183-189
63. Vidali, M., Vietala, J., Occhino, G., Ivaldi, A., Sutti, S., Niemelä, O., Albano, E., 2007. Immune responses toward oxidative stress-derived antigens sustain inflammation in alcoholic liver disease. submitted for publication.
64. Yip W.W., and Burt A.D. Alcoholic liver disease. Semin. Diagn. Pathol. 23 (2006) 149-160